ALKS · US market
ALKERMES PLC SHS
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$6.80bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- US$66.12m
- Latest-quarter run-rate earnings
- US$2.00m
- Latest fiscal-year earnings
- US$241.66m
- Trailing revenue
- US$1.67bn
- Latest-quarter run-rate revenue
- US$1.98bn
- Latest fiscal-year revenue
- US$1.48bn
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- FBT · First Trust NYSE Arca Biotechnology Index Fund4.24% weight · Holdings dated 30 June 2026
- IBRN · iShares Neuroscience and Healthcare ETF4.19% weight · Holdings dated 21 August 2026
- PSCH · Invesco S&P SmallCap Health Care ETF3.71% weight · Holdings dated 31 May 2026
- NSMAX · Nuveen Small/Mid Cap Value Fund Class A2.21% weight · Holdings dated 30 June 2026
- NSCFX · Nuveen Small-Cap Value Opportunities Fund Class R62.05% weight · Holdings dated 30 June 2026
- XSHQ · Invesco S&P SmallCap Quality ETF1.76% weight · Holdings dated 31 May 2026
- LSMNX · Loomis Sayles Small/Mid Cap Growth Fund Class N1.74% weight · Holdings dated 30 June 2026
- AZBAX · Virtus Small-Cap Fund Class A1.67% weight · Holdings dated 30 June 2026
- ASQAX · American Century Small Company Fund A Class1.48% weight · Holdings dated 30 June 2026
- FSCWX · Nuveen Small Cap Value Fund Class R61.38% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.